321 related articles for article (PubMed ID: 21586824)
1. Treatment of an autoimmune encephalomyelitis mouse model with nonmyeloablative conditioning and syngeneic bone marrow transplantation.
Meng L; Ouyang J; Zhang H; Wen Y; Chen J; Zhou J
Restor Neurol Neurosci; 2011; 29(3):177-85. PubMed ID: 21586824
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic bone marrow transplantation in models of experimental autoimmune encephalomyelitis: evidence for a graft-versus-autoimmunity effect.
Van Wijmeersch B; Sprangers B; Rutgeerts O; Lenaerts C; Landuyt W; Waer M; Billiau AD; Dubois B
Biol Blood Marrow Transplant; 2007 Jun; 13(6):627-37. PubMed ID: 17531772
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAE.
Xu B; Haviernik P; Wolfraim LA; Bunting KD; Scott DW
Mol Ther; 2006 Jan; 13(1):42-8. PubMed ID: 16219491
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic effect of allogenic bone marrow mesenchymal stem cell transplantation on EAE mouse].
Liu P; Xuan X; Zhu J; Guan S; Du Y; Li Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):798-801. PubMed ID: 23948402
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of experimental autoimmune encephalitis by novel peptides: involvement of T regulatory cells.
Shapira E; Brodsky B; Proscura E; Nyska A; Erlanger-Rosengarten A; Wormser U
J Autoimmun; 2010 Aug; 35(1):98-106. PubMed ID: 20434883
[TBL] [Abstract][Full Text] [Related]
6. Non-myeloablative transplantation of bone marrow expressing self-antigen establishes peripheral tolerance and completely prevents autoimmunity in mice.
Hosseini H; Oh DY; Chan ST; Chen XT; Nasa Z; Yagita H; Alderuccio F; Toh BH; Chan J
Gene Ther; 2012 Nov; 19(11):1075-84. PubMed ID: 22071968
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of polyclonal tregs does not require rapamycin in a low-dose irradiation bone marrow transplantation model.
Pilat N; Klaus C; Gattringer M; Jaeckel E; Wrba F; Golshayan D; Baranyi U; Wekerle T
Transplantation; 2011 Aug; 92(3):280-8. PubMed ID: 21697774
[TBL] [Abstract][Full Text] [Related]
8. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
[TBL] [Abstract][Full Text] [Related]
9. Human mesenchymal stem cells upregulate CD1dCD5(+) regulatory B cells in experimental autoimmune encephalomyelitis.
Guo Y; Chan KH; Lai WH; Siu CW; Kwan SC; Tse HF; Wing-Lok Ho P; Wing-Man Ho J
Neuroimmunomodulation; 2013; 20(5):294-303. PubMed ID: 23899693
[TBL] [Abstract][Full Text] [Related]
10. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
11. Disease progression after bone marrow transplantation in a model of multiple sclerosis is associated with chronic microglial and glial progenitor response.
Cassiani-Ingoni R; Muraro PA; Magnus T; Reichert-Scrivner S; Schmidt J; Huh J; Quandt JA; Bratincsak A; Shahar T; Eusebi F; Sherman LS; Mattson MP; Martin R; Rao MS
J Neuropathol Exp Neurol; 2007 Jul; 66(7):637-49. PubMed ID: 17620989
[TBL] [Abstract][Full Text] [Related]
12. Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation.
Elkin G; Prigozhina TB; Slavin S
Exp Hematol; 2004 Jun; 32(6):579-84. PubMed ID: 15183899
[TBL] [Abstract][Full Text] [Related]
13. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors.
Kassis I; Petrou P; Halimi M; Karussis D
Immunol Lett; 2013; 154(1-2):70-6. PubMed ID: 23994102
[TBL] [Abstract][Full Text] [Related]
15. Time point is important for effects of syngeneic bone marrow transplantation for type 1 diabetes in mice.
Wen Y; Ouyang J; Li W; Chen J; Liu Y; Meng L; Zhang H; Zhou X
Transplant Proc; 2009 Jun; 41(5):1801-7. PubMed ID: 19545732
[TBL] [Abstract][Full Text] [Related]
16. [Th17/Treg unbalance is involved in the pathogenesis of experimental autoimmune encephalomyelitis].
Lu P; Wang M; Zheng P; Hou J; Zhang Y; Deng Y; Cao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1013-7. PubMed ID: 25270199
[TBL] [Abstract][Full Text] [Related]
17. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
[TBL] [Abstract][Full Text] [Related]
18. Paralysis of CD4(+)CD25(+) regulatory T cell response in chronic autoimmune encephalomyelitis.
Matsumoto Y; Sakuma H; Kohyama K; Park IK
J Neuroimmunol; 2007 Jul; 187(1-2):44-54. PubMed ID: 17499858
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
PifarrĂ© P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; GarcĂa A
Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
[TBL] [Abstract][Full Text] [Related]
20. CD4(+)CD25(+) regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis.
Jee Y; Piao WH; Liu R; Bai XF; Rhodes S; Rodebaugh R; Campagnolo DI; Shi FD; Vollmer TL
Clin Immunol; 2007 Oct; 125(1):34-42. PubMed ID: 17632037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]